MOLECULAR TECHNOLOGIES LABORATORIES LLC

Biotech · Acquired

A novel growth hormone receptor antagonist (NGHRA) that reduces circulating IGF-1 levels to treat Alzheimer's disease and related dementias

Grants
$498K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
10
1 granted · 9 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Development of a Growth Hormone Receptor antagonist for the delay or prevention of ADRD$275,070
Federal grantDepartment of Health and Human Services · Phase I · Development of a Growth Hormone Receptor antagonist for the delay or prevention of ADRD$222,594
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1263Proteovant Therapeutics——
1264Pelthos Therapeutics Inc.—$69M
1265Mediar Therapeutics—$75M
1266MOLECULAR TECHNOLOGIES LABORATORIES LLC——
1267MARTINGALE LABS, INC.——
1268Monte Rosa Therapeutics, Inc.—$143M
1269Tyra Biosciences, Inc.—$200M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 1 granted of 10
  • Methods For Treating Alzheimers Disease And Related Dementias And Aging Using Pegylated Growth Hormone Receptor Antagonistsapplication
  • Growth Hormone Receptor Antagonists Exhibiting Increased Receptor Binding Properties And Increased Serum Half-lifeapplication
  • Growth Hormone Antagonist And Anti-cancer Composition Combination Therapyapplication
  • Therapeutic Pegylated Growth Hormone Antagonistsgranted
  • Pegylated Growth Hormone Antagonistsapplication
  • Methods For Treating Alzheimers Disease And Related Dementias And Aging Using Pegylated Growth Hormone Receptor Antagonistsapplication
  • Pegylated Growth Hormone Antagonistsapplication
  • Methods For Treating Alzheimer’s Diseaseand Related Dementias Using Pegylated Growth Hormone Antagonistsapplication
  • Growth Hormone Antagonist And Anti-cancer Composition Combination Therapyapplication
  • Therapeutic Pegylated Growth Hormone Antagonistsapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.